Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy.

Michael J Thorpy,Danielle Hyman,Gregory S Parks,Abby Chen,Catherine Foley,Beth Baldys,Diane Ito,Haramandeep Singh

Clinical therapeutics（2022）

引用 3|浏览0

暂无评分

摘要

In a real-world study, physicians initiated solriamfetol therapy at 75 mg/d for most patients with narcolepsy, adjusted dosages once, tapered stimulants, and abruptly discontinued therapy with wake-promoting agents.

查看译文

关键词

JZP-110,Sunosi,excessive daytime sleepiness,narcolepsy,pharmacotherapy,real-world evidence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要